Multiple myeloma: consensuses and controversies
Faith Davies et al.
Navigating advances in the myeloma landscape over the past couple of years
Anti-BCMA CAR T-cells for MM: durable clinical responses with bb2121
AML immunotherapy: patients need to be well informed
An update on immunotherapy for multiple myeloma in 2016
Ignacio Melero Bermejo et al.